| Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia. | |
| | |
MedLine Citation:
|
PMID: 20078490 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AIMS: To explore service provision and the range of problems that New South Wales (NSW) and Victoria (VIC) community pharmacists providing opioid substitution treatment (OST) have experienced with clients and prescribers. DESIGN: ross-sectional postal survey. SETTING: All community pharmacies providing OST in NSW (n = 593) and VIC (n = 393), Australia. PARTICIPANTS: Completed questionnaires were received from 669 pharmacists (68% response rate). MEASUREMENTS: The questionnaire addressed pharmacy characteristics, recent problems experienced with clients including refusal to dose, provision of credit for dispensing fees, termination of treatment, responses of pharmacists to problems experienced with clients, as well as problems experienced with OST prescribers. FINDINGS: In the preceding month, 41% of pharmacists had refused to dose a client for any reason, due most commonly to expired prescriptions (29%), or > or issed doses (23%). Terminating a client's treatment in the past month was reported among 14% of respondents, due most commonly to inappropriate behaviour and missed doses. Treatment termination was reported by a significantly higher proportion of pharmacists in VIC (P < 0.001). Treatment termination in last month was predicted having more clients (P < 0.001), the provision of buprenorphine treatment (P = 0.008), having a separate dosing area (P = 0.021), and being a female pharmacist (P = 0.013). Past month refusal to dose was predicted by the pharmacy being in VIC (P < 0.001) and having more clients (P < 0.001). Problems experienced most commonly in the past month with prescribers were difficulty contacting prescriber (21%) and provision of takeaway doses to clients considered unstable by the pharmacist (19%) (higher in VIC: both P < 0.001). CONCLUSIONS: This study highlights the range of problems experienced by community pharmacists in the delivery of OST and the consequences for people in treatment. Particular attention should be focused upon considering number of clients per pharmacy and improving professional communication between pharmacists and prescribers. |
| | |
Authors:
|
Adam R Winstock; Toby Lea; Janie Sheridan |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Addiction (Abingdon, England) Volume: 105 ISSN: 1360-0443 ISO Abbreviation: Addiction Publication Date: 2010 Feb |
Date Detail:
|
Created Date: 2010-01-18 Completed Date: 2010-06-04 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9304118 Medline TA: Addiction Country: England |
Other Details:
|
Languages: eng Pagination: 335-42 Citation Subset: IM |
Affiliation:
|
Drug Health Services, Sydney South West Area Health Service, Sydney, NSW, Australia. adam.winstock@kcl.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Analgesics, Opioid
/
economics,
supply & distribution Buprenorphine / economics, supply & distribution Community Pharmacy Services / statistics & numerical data* Cross-Sectional Studies Female Humans Interprofessional Relations Male Medication Adherence / statistics & numerical data Methadone / economics, supply & distribution New South Wales Opioid-Related Disorders / drug therapy*, economics Professional-Patient Relations Questionnaires Refusal to Treat / statistics & numerical data Victoria |
| Chemical | |
Reg. No./Substance:
|
0/Analgesics, Opioid; 52485-79-7/Buprenorphine; 76-99-3/Methadone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic.
Next Document: Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.